[PERSON]
Vanita R. Aroda
Featured in 1 tracked story · first seen
Situations
GLP-1 drugs: safety, clinical trends, and market impacts
210 clusters · 766 sources · last updated
Latest: UK consumer demand shifts following weight-loss pill approval
Since mid-2026, the expansion of GLP-1 agents for obesity has been accompanied by intensified safety monitoring and evolving clinical data. While research suggests secondary benefits—including a 21% lower risk of fragili